These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32968362)

  • 1. Multivisceral Resection of Advanced Pelvic Tumors: From Planning to Implementation.
    Mirnezami R; Mirnezami A
    Clin Colon Rectal Surg; 2020 Sep; 33(5):268-278. PubMed ID: 32968362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic exenteration for locally advanced and recurrent rectal cancer-how much more?
    Lau YC; Brown KGM; Lee P
    J Gastrointest Oncol; 2019 Dec; 10(6):1207-1214. PubMed ID: 31949941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and Limitations of Pelvic Exenteration Surgery.
    Lampe B; Luengas-Würzinger V; Weitz J; Roth S; Rawert F; Schuler E; Classen-von Spee S; Fix N; Baransi S; Dizdar A; Mallmann P; Schaser KD; Bogner A
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative.
    PelvEx Collaborative
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenterative surgery for palliation of malignant disease in the robotic era.
    Boustead GB; Feneley MR
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):740-6. PubMed ID: 20719487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades.
    Waters PS; Peacock O; Warrier SK; Wakeman C; Eglinton T; Lynch AC; Frizelle FA; Heriot AG; McCormick J
    Eur J Surg Oncol; 2019 Dec; 45(12):2325-2333. PubMed ID: 31303376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of Robotics in Pelvic Exenteration Surgery for Locally Advanced Rectal Cancer: A Narrative Review.
    Chang TP; Chok AY; Tan D; Rogers A; Rasheed S; Tekkis P; Kontovounisios C
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Exenterative Surgery in Advanced Urological Neoplasms.
    Cunneen C; Kelly M; Nason G; Ryan E; Creavin B; Winter D
    Curr Urol; 2020 Jun; 14(2):57-65. PubMed ID: 32774229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.
    Nakafusa Y; Tanaka T; Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Dis Colon Rectum; 2004 Dec; 47(12):2055-63. PubMed ID: 15657654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptive Femoral-Femoral Crossover Grafting of Artery and Vein Before Pelvic Exenterative Surgery for Locally Advanced and Recurrent Pelvic Malignancy Involving the Aortoiliac Axis.
    Peacock O; Smith N; Waters PS; Park-Yun Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
    Dis Colon Rectum; 2021 Jan; 64(1):e2-e5. PubMed ID: 33306540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of radical cystectomy.
    Buscarini M; Pasin E; Stein JP
    Minerva Urol Nefrol; 2007 Mar; 59(1):67-87. PubMed ID: 17431372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
    Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
    Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.